AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vriglim M 0.5 Tablet

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Glimepiride (0.5gm) + Metformin (500mg)

Overview Vriglim M 0.5 Tablet

Diabexe Duo 0.5mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabexe Duo 0.5mg with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially leading to nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating a healthy diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.

Uses of Vriglim M 0.5 Tablet

Managing type 2 diabetes

Major Benefits of Vriglim M 0.5 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vriglim M 0.5mg tablets should be administered with a meal.

Common Side effects of Vriglim M 0.5 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Vriglim M 0.5 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vriglim M 0.5 Tablet with a meal.

How Vriglim M 0.5 Tablet works:

Vriglim M 0.5 Tablet combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vriglim M 0.5 Tablet and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vriglim M 0.5 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Vriglim M 0.5 Tablet are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Vriglim M 0.5 Tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. Vriglim M 0.5 Tablet is contraindicated in individuals with severely compromised kidney function. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Vriglim M 0.5 Tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for those with mild to moderate hepatic dysfunction; the medication is contraindicated in patients with severe liver disease.

What if you forget to take Vriglim M 0.5 Tablet :

Should you forget a Vriglim M 0.5 Tablet dose, take it immediately if possible. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vriglim M 0.5 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vriglim M 0.5 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Vriglim M 0.5 Tablet can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vriglim M 0.5 Tablet and seek immediate medical attention.
Vriglim M 0.5 Tablet combines glimepiride and metformin to treat type 2 diabetes mellitus (DM) in adults. It helps control blood sugar when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Vriglim M 0.5 Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Vriglim M 0.5 Tablet use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Vriglim M 0.5 Tablet can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are used concurrently. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Vriglim M 0.5 Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Vriglim M 0.5 Tablet
43
MRP 50
13% off